Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative

• Κύριοι συγγραφείς: Colombo GL (Συγγραφέας), Di Matteo S (Συγγραφέας), Martinotti C (Συγγραφέας), Jugl SM (Συγγραφέας), Gunda P (Συγγραφέας), Naclerio M (Συγγραφέας), Bruno GM (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Dove Medical Press, 2018-08-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Giorgio L Colombo,1,2 Sergio Di Matteo,2 Chiara Martinotti,2 Steffen M Jugl,3 Praveen Gunda,4 Mariantonietta Naclerio,5 Giacomo M Bruno2 1Department of Drug Science, Pavia University, Pavia, Italy; 2S.A.V.E. S.r.l. Studi Analisi Valutazioni Economiche Health Economics & Outcomes Research - resea...